Bicyclic compounds having antimitotic and/or antitumor...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 491/048 (2006.01) A61K 31/517 (2006.01) A61K 31/519 (2006.01) A61P 35/00 (2006.01) C07D 239/70 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2730314

The present invention provides bicyclic compounds, pharmaceutically acceptable salts, prodrugs, solvates, and hydrates thereof, having antimitotic activity, anti-multidrug resistance activity, such as for example P-glycoprotein inhibition, and antitumor activity, and which inhibit paclitaxel sensitive and resistant tumor cells. Also provided are methods of utilizing these compounds for treating tumor cells and inhibiting mitosis of cancerous cells.

La présente invention porte sur des composés bicycliques, des sels pharmaceutiquement acceptables, des pro-médicaments, des solutés et des hydrates de ceux-ci, ayant une activité antimitotique, une activité de résistance anti-médicament multiple, comme, par exemple, une inhibition de la glycoprotéine P, et une activité anti-tumorale, et qui inhibe les cellules tumorales sensibles et résistantes au paclitaxel. L'invention porte également sur des procédés d'utilisation de ces composés pour traiter des cellules tumorales et inhiber la mitose de cellules cancéreuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bicyclic compounds having antimitotic and/or antitumor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic compounds having antimitotic and/or antitumor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic compounds having antimitotic and/or antitumor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2032616

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.